跳至主要内容
临床试验/CTRI/2022/09/045847
CTRI/2022/09/045847尚未招募不适用

Evaluation of Chemotherapy-Induced Peripheral Neuropathy, Sarcopenia, and Fatigue in Children with Acute Lymphoblastic Leukemia and Lymphoma in Maintenance Phase.

Manipal Academy of Higher Education1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年9月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
1
主要终点
Severity of side effects of chemotherapy

研究概览

简要总结

To evaluate the magnitude of chemotherapy induced peripheral neuropathy, fatigue and sarcopenia in children with Acute lymphoblastic leukaemia and Lymphoma during the maintenance phase.

研究设计

研究类型
Observational

入排标准

年龄范围
5.00 Year(s) 至 18.00 Year(s)(—)
性别
All

入选标准

  • Children of 5-18 years during maintenance phase with Acute Lymphoblastic Leukemia and Lymphoma receiving chemotherapy.
  • The ECOG score <2 will be included.

排除标准

  • Participants with severe orthopedic and neurological dysfunctions that may limit them from participating in the study.
  • Participants with Metastasis.

结局指标

主要结局

Severity of side effects of chemotherapy

时间窗: 3-Time points, i.e., at start of maintenance phase, at 3 months and and at 6 months of maintenance phase

次要结局

  • Help in evaluating the overall quality of life of children through physical performance, fatigue and sarcopenia assessment.(3-Time points, i.e., at start of maintenance phase, at 3 months and and at 6 months of maintenance phase)

研究者

申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验